Hey guys, apologies for the formatting in the following. Playing monster trucks with my youngest, realised it may be of interest, so just pasting a text I sent to a mate yesterday:
My personal guess/take is that the announcement reeks of Pfizer. Specifically, the CRO. I'm drawing a bit of a long bow here, but a few points:
Firstly, I think (guessing) Parexel are too expensive for us.
Secondly, Parexel has had a decade long partnership with Pfizer: https://bit.ly/3mdNAEP
Finally, when Sarepta's DMD drug was approved, a Ronald Farkas quit the FDA quit and went to Parexel: https://bit.ly/3zY6yV1
i.e. If we were hoping to get into bed with Sarepta, this CRO would be an interesting choice.
Also worth looking at their experience in running trials across the US/EU. I'm excited!
- Forums
- ASX - By Stock
- PER
- Where others have failed will Atl1102 succeed ?
Where others have failed will Atl1102 succeed ?, page-454
-
-
- There are more pages in this discussion • 643 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.0¢ |
Change
0.004(4.65%) |
Mkt cap ! $81.13M |
Open | High | Low | Value | Volume |
8.6¢ | 9.1¢ | 8.5¢ | $181.6K | 2.049M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10344 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 64275 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10344 | 0.087 |
1 | 100000 | 0.085 |
2 | 155000 | 0.084 |
1 | 150000 | 0.083 |
1 | 36585 | 0.082 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 64275 | 1 |
0.091 | 106821 | 1 |
0.092 | 50000 | 1 |
0.093 | 50000 | 1 |
0.094 | 160000 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online